Navigation Links
Fox Chase Cancer Center's Ning Wong receives ASCO Cancer Foundation Career Development Award
Date:5/14/2008

The American Society of Clinical Oncology Cancer Foundation has selected Yu-Ning Wong, M.D., M.S.C.E., of Fox Chase Cancer Center, as one of 13 clinicians to receive a 2008 Career Development Award. Career Development Awards are presented to physicians in their second, third or fourth year as full-time faculty members in an academic setting. This award marks the third time ASCO has honored Wong's accomplishments since she began her professional career in oncology in 2002.

Wong is an attending physician in Fox Chase Cancer Center's department of medical oncology and holds a dual appointment as an associate member of the Center's divisions of medical science and population science. Her clinical interests include genitourinary malignancies such as kidney, bladder, prostate and testicular cancers. Wong also conducts health services research including cost-effectiveness analysis and research on treatment outcomes.

"I believe it is essential for physicians to understand how we care for cancer patients as a society," said Wong. "I study large national databases to measure the outcomes of men with prostate cancer, and I study outcomes of treatment for colon cancer and breast cancer. I enjoy these endeavors because they encourage me to think about problems from many different angles, an important aspect of being a medical oncologist."

Each of this year's Clinical Development Award winners will receive a three-year grant totaling $200,000 to establish an independent clinical cancer research program. This is the third award ASCO has given Wong. In 2005, she was awarded a Young Investigator Award, which provides grants to leading young clinical oncology researchers in a broad range of specialties worldwide. In 2004, she received an ASCO Merit Award given to fellows who submit high-quality abstracts selected for presentation at the ASCO Annual Meeting.

"We are currently in the longest period of flat and declining federal fundin
'/>"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
414-312-7085
Fox Chase Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased by $15 Million
2. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend, Authorizes Share Repurchase Program and Announces Election of New Officers
3. DaVita Board of Directors Increases Share Repurchase Authorization
4. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
5. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
6. HealthSouth to Purchase The Rehabilitation Hospital of South Jersey
7. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
8. Saratoga Hospital Purchases Three IDC DR Systems
9. Somanetics Announces Share Repurchase Program
10. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
11. Health Fitness Announces $2.5 Million Stock Repurchase Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ntists have conducted a study, the first of its ki...he experiment was performed on mice, yet scientist.... The cause for Type 2 diabetes is still unknow... this. Yet one of the features of this disease is...
...archers at UT Southwestern Medical Center have fou...n inducing hypertension. "We have discovered that...f the risk of hypertension, it actually induces hy...asin, associate professor of internal medicine and...
...ious studies have shown that inflammation may some...alignant. UCSF scientists// have now discovered wh...cally, the "innate" immune system's Pac-Man-like w...and destroy invading microbes when receptors on th...
...archers at San Antonio's South Texas Center for Em...onio Health Science Center// (UTHSC) have come tog...hat will prevent Chlamydia. Chlamydia is a common...y the bacterium, Chlamydia trachomatis, which can ...
Other Medicine News:Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:C-Reactive Protein Induces Hypertension 2Health News:Inflammation can Lead to Cancer 2Health News:A Combined Research for Producing Chlamydia Vaccine Begins 2
(Date:8/19/2008)...swire-FirstCall/ -- Vical Incorporated,(Nasdaq: V...h the Karolinska,Institutet (KI), a leading Europe...or Infectious Disease Control (SMI), a governmenta...adjuvant with the Biojector(R),2000 needle-free in...,OTCBB: BJCT) for a multivalent preventive DNA vac...
(Date:8/19/2008)... /- VION,PHARMACEUTICALS, I...d,entered into an agreement with the Dutch-Belgian...the "HOVON") to conduct a clinical trial of,laromu...emission-induction,therapy in patients aged 18-65 ...ia (AML) and high-risk myelodysplasia (MDS)., Ala...
(Date:8/18/2008).../PRNewswire-USNewswire/ -- Due to an,exceptionally...s in,southeastern Pennsylvania, the Department of ...ill be stepping up efforts this week to combat the...ely to carry -- the virus., While only one human ...s year (a 27-year-old Montgomery County woman), DE...
(Date:8/18/2008)...re-USNewswire/ -- Boston University and Aubrey,Mil... Human Genetics, Inc.,("CHG") and Director of the ...nounced that CHG will no longer offer testing serv...tics, Inc., These patented tests include tests re... or Connexin 26 mutations, developmental disorders...
Breaking Medicine Technology:Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 1Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 2Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 3Gene mutation improves leukemia drugs effect 22091 1Gene mutation improves leukemia drugs effect 22091 2People with lower incomes lower education levels have higher death rates 22089 1People with lower incomes lower education levels have higher death rates 22089 2Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 1Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 2
..., 2007 /PRNewswire-FirstCall/ --,SuperGen Inc. ann...ons at the American Association for Cancer Researc...ese presentations,will focus on data concerning ma...ng its lead tyrosine kinase inhibitor compound,MP...target involved,in cancer cell drug resistance. Pr...
... 2007 -- CytImmune, a,clinical stage nanomedicine...ization of multifunctional, tumor-targeted therapi...at the 43rd American,Society of Clinical Oncology ...poster session will take place from 8:00 am to 12,...mmune will,present the poster abstract entitled "P...
Other Medicine Technology:SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2
...N 1700 was developed to address hematology needs i... use, low maintenance, closed-tube sampling, small...tures expected in the modern hematology lab. New c...ticated data management, and simplification of dat...
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously.
For physicians looking for a traditional ECG who also want advanced communications with electronic storage features, the Atria 3100 combines the best of both worlds. It maintains the popular compact,
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: